Your browser doesn't support javascript.
loading
High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection.
Zhou, Chenhao; Sun, Jialei; Zheng, Zhiyuan; Weng, Jialei; Atyah, Manar; Zhou, Qiang; Chen, Wanyong; Zhang, Yuan; Huang, Jiaxing; Yin, Yirui; Mao, Huarong; Zhang, Ziping; Yi, Yong; Ren, Ning.
Afiliação
  • Zhou C; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China.
  • Sun J; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Zheng Z; Institute of Fudan Minhang Academic Health System, Minhang Hospital, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Weng J; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China.
  • Atyah M; Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Zhou Q; Department of Interventional Radiology, Zhongshan Hospital, Fudan University and Shanghai Institute of Medical Imaging, Shanghai 200032, China.
  • Chen W; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China.
  • Zhang Y; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China.
  • Huang J; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China.
  • Yin Y; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China.
  • Mao H; Institute of Fudan Minhang Academic Health System, Minhang Hospital, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Zhang Z; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Yi Y; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ren N; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China.
Ann Transl Med ; 8(7): 466, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32395510

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China